Orap vs. Risperdal: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Orap and Risperdal. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 185,516 people who take Orap and Risperdal, and is updated regularly.
What is Orap?
Orap has active ingredients of pimozide. It is often used in gilles de la tourette syndrome. eHealthMe is studying from 544 Orap users. Check the latest studies of Orap.
What is Risperdal?
Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,728 Risperdal users. Check the latest studies of Risperdal.
185,516 people who take Orap and Risperdal are studied.
Drugs being compared in this study:
- Orap (pimozide)
- Risperdal (risperidone)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Orap:
- not at all: 6.45 %
- somewhat: 9.68 %
- moderate: 22.58 %
- high: 51.61 %
- very high: 9.68 %
Risperdal:
- not at all: 7.71 %
- somewhat: 24.73 %
- moderate: 33.78 %
- high: 25.07 %
- very high: 8.71 %
Want to compare Orap with Risperdal?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Janardhana P, Nagaraj AK, Basavanna PL, "Risperidone-induced skin rash", Indian journal of psychiatry, 2016 Jan .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Ray RK, Bashir MA, Rao S, "Co-Administration of Risperidone and Sodium Valproate Causing Bilateral Chronic Exertional Lower Leg Compartment Syndrome", Open Journal of Orthopedics, 2014 Apr .
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
- Janardhana P, Nagaraj AK, Basavanna PL, "Risperidone-induced skin rash", Indian journal of psychiatry, 2016 Jan .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Ray RK, Bashir MA, Rao S, "Co-Administration of Risperidone and Sodium Valproate Causing Bilateral Chronic Exertional Lower Leg Compartment Syndrome", Open Journal of Orthopedics, 2014 Apr .
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Orap:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Risperdal:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on pimozide and risperidone (the active ingredients of Orap and Risperdal, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Gemcitabine Hydrochloride and Neulasta - 4 seconds ago
- Escitalopram and Indigestion for Men aged 40-49 - 8 seconds ago
- Escitalopram and Stomach Upset for Men aged 40-49 - 8 seconds ago
- Escitalopram and Uncomfortable Fullness After Meals for Men aged 40-49 - 8 seconds ago
- Escitalopram and Dyspepsia for Men aged 40-49 - 9 seconds ago
- Escitalopram and Upset Stomach for Men aged 40-49 - 9 seconds ago
- Drug interactions of Sandostatin and Colace - 13 seconds ago
- Drug interactions of Maxzide and Hydrochlorothiazide - 14 seconds ago
- Drug interactions of Motrin and Kaletra - 15 seconds ago
- Drug interactions of Mircera and Cinacalcet Hydrochloride - 16 seconds ago